Gentiluomo, M., Capurso, G., Morelli, L., Ermini, S., Pasquali, C., Latiano, A., . . . Campa, D. (2022). Genetically determined telomere length is associated with pancreatic neuroendocrine neoplasms onset. Neuroendocrinology, 112(12), . https://doi.org/10.1159/000524659
Chicago Style (17th ed.) CitationGentiluomo, Manuel, et al. "Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset." Neuroendocrinology 112, no. 12 (2022). https://doi.org/10.1159/000524659.
MLA (9th ed.) CitationGentiluomo, Manuel, et al. "Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset." Neuroendocrinology, vol. 112, no. 12, 2022, https://doi.org/10.1159/000524659.
Warning: These citations may not always be 100% accurate.